Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

International Ophthalmology - Vision 2020

Klauss V.
University Eye Hospital, LMU, Munich

Purpose: In 1999 the programme "Vision 2020 - The Right to Sight, Global Initiative for the Elimination of Avoidable Blindness by the Year 2020" was launched by World Health Organisation (WHO), International Agency for the Prevention of Blindness (IAPB), governments and non governmental organizations (NGO´s). The reason was the high number of blind worldwide, to date 50 Mio with an annual increase of 1 to 2 Mio. 4 years after the launch we must query, if obvious successes can be monitored.
Method, Results: The programme Vision 2020 was started on a global level, later in-augurated for the 5 continents and country level. Official launches with participation of politicians, press and the public were geared at attracting the interest of the public and of patients. International or national workshops have produced strategies for the coming 5 years for countries and districts for practical implementation of the programme. Cooperations at international level under participation of WHO, Donor Countries, NGO´s, thrive to mobilize the necessary financial resources. Lions International Programme - Sight First- is a major donor, but also drug companies like Merck, Sharp and Dome and Pfizer donate medicines for mass therapy in Africa and Asia. Ivermectin for the treatment of onchocerciasis and azithromycin for treatment of trachoma are of greatest interest.
So far in Asia the focus is on programmes for catarct surgery with the aim to increase the cataract surgical rate, whereas


Zurück | Back